Truehelm Charts New Course in Healthcare PE After Rebrand

MINNEAPOLIS, MN – April 02, 2026 – Healthcare private equity firm TT Capital Partners has officially rebranded as Truehelm, a strategic move designed to underscore its independence and sharpen its focus on the burgeoning healthcare IT and tech-enabled services sectors. The new name and identity, effective immediately, arrive on the heels of a successful third fundraise, positioning the firm to deploy significant capital into companies poised to disrupt how healthcare is delivered and managed.

This rebranding is more than a simple name change; it marks the final chapter in the firm's evolution into a fully independent asset manager. Founded in 2011, TT Capital Partners initially operated under the umbrella of TripleTree Holdings, an entity that also included the investment bank TripleTree. A pivotal moment came in 2021 when the investment banking arm was sold to CapitalOne, a transaction that set the stage for the private equity firm to operate on its own. The new brand, Truehelm, is a deliberate declaration of this autonomy.

“The name Truehelm reflects our standing as an independent asset manager and expresses who we are – reliable, principled partners guiding healthcare companies through pivotal stages of growth,” said Dawn Owens, Truehelm CEO and Partner, in the official announcement. “We look forward to continuing our legacy of combining deep healthcare and operating expertise with financial services acumen to deliver enduring success.”

Capitalizing on a Successful Fundraise

The timing of the rebrand is directly linked to the firm's recent financial momentum. The new identity was unveiled following the successful completion of Truehelm's third fundraise, TTCP Fund III, in September 2025. While the firm has not disclosed the specific size of this latest fund, it follows a period of significant capital accumulation. In late 2024, the firm, then still TT Capital Partners, announced it had reached $1 billion in assets under management, a milestone likely connected to the successful closing of this third fund.

This fresh infusion of capital, combined with a clear, independent identity, empowers Truehelm to more aggressively pursue its investment thesis. The firm is now armed with substantial resources to back entrepreneurial leaders and support what it calls “financially disciplined, disruptive businesses.” The rebrand acts as a clear signal to both investors and potential portfolio companies that Truehelm is a focused, well-capitalized partner ready to make an impact.

A Disciplined Thesis in a Competitive Market

Truehelm’s investment strategy is tightly focused on two of the most dynamic segments of the healthcare industry: healthcare IT and tech-enabled services. The firm seeks to identify and partner with companies that are not just participating in the market but are positioned to become leaders. An examination of its portfolio reveals a clear pattern of investing in businesses that address critical challenges across the healthcare ecosystem.

Investments include companies like CorroHealth, which provides technology-driven solutions to optimize the complex revenue cycle for hospitals and health systems, and MacroHealth, a technology platform aimed at cost containment and network optimization for health payers. The firm has also backed CareConnectMD, a company focused on managing care for high-needs Medicare populations through value-based arrangements.

Truehelm's thesis extends to direct patient care and wellness. Its portfolio includes Accanto Health, a provider of clinically-integrated treatment for eating disorders, and a 2023 investment in Pyx Health, a tech-enabled service that uniquely addresses the critical issues of loneliness and social isolation. Other investments touch on genomics, AI-enabled software, and women's health, demonstrating a broad yet disciplined approach to fostering innovation that improves how healthcare is delivered, managed, and financed.

Navigating the Booming Healthcare PE Landscape

Truehelm’s strategic repositioning comes at a time of intense activity and competition in the healthcare private equity space. The market saw a record-breaking year in 2025, with global deal value soaring to an estimated $191 billion. Healthcare IT was a major driver of this activity, with deal value in the provider segment alone doubling to an estimated $32 billion.

Industry analysts note that this heated environment, fueled by investor confidence and the transformative potential of technologies like AI, is putting pressure on firms to differentiate themselves. Larger funds are increasingly competing for assets, forcing mid-market investors like Truehelm to leverage deep sector expertise and operational value-add to stand out. According to industry analysis reported by Minneapolis Today, the rebrand is a shrewd move to align the firm’s brand with evolving market trends and investor preferences, potentially helping it attract new capital and secure promising deals.

By adopting the Truehelm identity, the firm is making a clear statement about its role as a specialist navigator in a complex market. It is positioning itself not as a generalist, but as a dedicated partner with the specific knowledge required to steer healthcare technology companies toward market leadership.

Leadership at the Helm

Guiding the firm through this transition and into its next phase of growth is CEO and Partner Dawn Owens. With over 30 years of experience in the healthcare sector, Owens brings a wealth of operational and strategic expertise. Before joining the firm in 2014, she held senior leadership roles at major industry players, including serving as CEO of OptumHealth, a UnitedHealth Group company.

Owens was central to the firm’s journey to independence, having been appointed CEO of TripleTree Holdings in 2020 and leading the strategic sale of the investment banking division a year later. Her leadership extends directly into the portfolio, where she serves on the boards of several Truehelm companies, including Accanto Health, CareConnectMD, and MacroHealth. This hands-on involvement reflects the firm's philosophy of being a collaborative partner, not just a source of capital. Her deep engagement in the firm’s Investment, Risk, and ESG committees further underscores her comprehensive role in shaping Truehelm's strategic direction and operational integrity. As the healthcare industry continues its rapid technological evolution, Truehelm has firmly positioned itself at the steering wheel, ready to guide the next generation of market-leading companies.